RxDoctor Payments Data

Ermias Abebe, MD

Orthopaedic Surgery · Texarkana, TXNPI 1548558273

Payments from drug & device makers

$8,980in general payments, 2019–2025

Across 45 payments — averaging $199.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$4K
  • Stryker$3K
  • Midsouth Orthopedics Inc.$1K
  • Johnson & Johnson$215
  • Bioventus LLC$58
  • Sanofi-aventis U.S. LLC$15
  • plus $13 from 1 others

What the payments were for

  • Consulting fees$3,15035%
  • Travel & lodging$3,28537%
  • Food & beverage$1,37515%
  • Education$1,17013%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medical Device Business Services, Inc.11$4,262
Stryker22$3,177
Midsouth Orthopedics Inc.5$1,240
Johnson & Johnson3$215
Bioventus LLC2$58
Sanofi-aventis U.S. LLC1$15
KCI USA, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,980 in reported general payments places this provider in the 60th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$109,811
Medicare patients
202
Services billed
564

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron Hcl35$230
Oxycodone Hcl47$173
Gabapentin28$155
Cephalexin14$72
Meloxicam11$13

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Texarkana

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →